Trials / Conditions / Atypical Chronic Myeloid Leukemia, BCR-ABL Negative

Atypical Chronic Myeloid Leukemia, BCR-ABL Negative

5 registered clinical trials studyying Atypical Chronic Myeloid Leukemia, BCR-ABL Negative.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic NCT01199562	City of Hope Medical Center	—
Terminated	Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload NCT01159067	City of Hope Medical Center	Phase 2
Terminated	Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Bloo NCT01076270	Fred Hutchinson Cancer Center	N/A
Completed	Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant NCT00795769	Fred Hutchinson Cancer Center	Phase 2
Completed	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors NCT00799461	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Phase 3